“showed a trend”

Immunohistochemistry The number of PV+-cells was not influenced by age (F(1, 35) = 0.01, p = 0.934) or sex ((F(1, 35) = 0.19, p = 0.192) but showed a trend: F(1, 35) = 3.6, p = 0.066.

Results Pilot Study and Power Calculation In the pilot study, comprised of tissue samples from Stanford and Rush, B-cell density in younger subjects (mean = 0.9 cells/cm 2 ± 1.5.) versus older subjects (mean = 3.0 cells/cm 2 ± 2.6) showed a trend (p = 0.066) indicating that B-cells might increase with age.

Corn-based SFD showed a trend towards a dose-response, with Corn20 having slightly higher breath hydrogen response when compared to Corn10 and Tapioca10 ( p = 0.066 and 0.052, respectively). 3.3.

Intestinal Electrophysiology in the Jejunum, Short-Chain Fatty Acid Concentration, and pH along the Intestinal Tract The jejunal electrophysiological parameters showed a trend for a decrease in the basal I SC due to the LA-treated cereals ( Table 2 ; p = 0.066) before the addition of Na 2 HPO 4 .

The jejunal villus height (VH) in the 8 mm group showed a trend toward an increase ( p = 0.066), and the ileal crypt depth (CD) was significantly lower ( p = 0.004), with significantly higher digestive enzyme activities in the jejunum and ileum ( p < 0.05).

The CRRT ≥7 days group showed a trend toward more long-term dialysis when they were compared with patients who suffered AKI but did not receive CRRT (aHR 2.72 [0.94–7.87], p = 0.066, Additional file 1 : Figure S1).

Only reduced renal function showed a trend toward an impact on OS ( P = 0.066) but not on DSS ( P = 0.334) survival in the subgroup of patients with non-muscle-invasive BC (MIBC).

In the entire study cohort, patients undergoing POCRT showed a trend toward higher locoregional control (LRC) rates than those treated with PORT alone at both 5 and 8 years (97 and 97 % versus 84 and 79 %, respectively; P = .066).

Response Times The analysis on the target faces only showed a trend for the three-way interaction ( F (1,21) = 3.75, p = 0.066, η p 2 = 0.15).

MYC gains showed a trend towards association with negative lymph node status (p = 0.066).

In multivariate analysis, high probability showed a trend towards association with the composite outcome (OR: 2.06; 95% CI: 0.96-4.54; P =.066).

Similarly, alterations in CDKN2A (including pathogenic/VUS mutations or CNV loss) showed a trend towards a higher frequency in the SCC group (6/8 cases, 75.0%) than in the CC group (2/8 cases, 25.0%) ( p = 0.066).

Interestingly, diabetes showed a trend toward reduced AAA risk (OR=0.386, 95% CI: 0.140–1.063, P=0.066).

Analysis of the association of serum S100A12 with survival in the whole cohort, including patients with moderate disease, showed a trend to higher levels in non-survivors ( p = 0.066). 4.

Higher body mass index also showed a trend toward increased risk ( p = 0.066).

The interaction of condition*order had no effect on NREM sleep (F 1,42 = 0.006, p = 0.939) but showed a trend-level effect on REM sleep (F 1,42 = 3.562, p = 0.066).

Univariate analysis showed a trend toward higher recurrence rates in females ( p = 0.066), advanced pN stage ( p = 0.1) and in cases with perineural invasion ( p = 0.095), without reaching statistical significance (Table 4 ).

When comparing baseline values (Pre-T1) with measurements obtained at the end of the protocol (Post-T10), serum serotonin levels showed a trend toward statistical significance (t(13) = −2.006, p = 0.066), accompanied by a moderate effect size (Cohen’s dz = 0.536).

Reduced nerve length showed a trend toward association with higher OSS scores ( r = −0.297, p = 0.066).

Lung metastasis showed borderline significance (HR 1.34; p = 0.071), and the use of bevacizumab in second or later lines showed a trend toward reduced mortality (HR 0.70; p = 0.066).

Positive staining for TDP‐43 showed a trend toward association with lower 1‐year K‐MMSE scores (beta [SE] = −9.45 [4.97], p = 0.066), while α‐synuclein‐positivity was not (beta [SE] = −1.34 [6.05], p = 0.825).

We found that 5 μM colibactin 742 showed a trend toward reduced proliferation in NTC cells ( P = 0.0661) but not PSMD4 −/− cells ( P = 0.9462), and that the proportion of BrdU cells was significantly higher in PSMD4 −/− cells after 1 μM ( P < 0.0001) and 5 μM ( P = 0.0078) colibactin treatment ( Fig.

However, HNSCC patients with advanced stages (stages III and IV) showed a trend towards lower levels of plasma NE (p = .0662).

Furthermore, the expression levels (median signal intensity, MSI) of CD57, a marker for terminal differentiation, among CD8 TEMRA showed a trend to be increased ( p = 0.0663) in PD (Fig. 1g ).

Despite their considerable melanoma cell expansion, MeWo-RhS only showed a trend towards an increase in M-CSF secretion ( p = 0.0664), compared to the RhS control ( Figure 2 b).